Qureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trialsNovember 2, 2026
Australian Health Data Evidence Network formed to standardize real world medical recordsNovember 2, 2026
General Space-grown organoids better replicate aggressive glioblastoma tumorsBy Healthcare Propulsion StaffOctober 30, 20260 Glioblastoma (GBM) is the most common malignant primary brain tumor in adults and is one of the most aggressive and…
